These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

231 related articles for article (PubMed ID: 2444212)

  • 1. Participation of the lone tryptophan residue of rat alpha-foetoprotein in its drug-binding sites. Comparison with rat serum albumin.
    Hervé F; Martin MT; Rajkowski K; Dessen P; Cittanova N
    Biochem J; 1987 May; 244(1):81-5. PubMed ID: 2444212
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Drug-binding properties of rat alpha 1-foetoprotein. Binding of warfarin, phenylbutazone, azapropazone, diazepam, digitoxin and cholic acid.
    Hervé F; Rajkowski K; Martin MT; Dessen P; Cittanova N
    Biochem J; 1984 Jul; 221(2):401-6. PubMed ID: 6206846
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Drug-binding properties of human alpha-foetoprotein.
    Hirano K; Watanabe Y; Adachi T; Ito Y; Sugiura M
    Biochem J; 1985 Oct; 231(1):189-91. PubMed ID: 2415113
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Drug-binding properties of rat alpha-foetoprotein. Specificities of the phenylbutazone-binding and warfarin-binding sites.
    Hervé F; Rajkowski KM; Martin MT; Dessen P; Cittanova N
    Biochem J; 1986 Oct; 239(2):451-8. PubMed ID: 2434073
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characterization of the aflatoxin B1-binding site of rat albumin.
    Dirr HW; Schabort JC
    Biochim Biophys Acta; 1987 Jul; 913(3):300-7. PubMed ID: 3109487
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fluorescence energy transfer study of the relationship between the lone tryptophan residue and drug binding sites in human serum albumin.
    Kasai S; Horie T; Mizuma T; Awazu S
    J Pharm Sci; 1987 May; 76(5):387-92. PubMed ID: 3656100
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characterization of an important drug binding area on human serum albumin including the high-affinity binding sites of warfarin and azapropazone.
    Fehske KJ; Schläfer U; Wollert U; Müller WE
    Mol Pharmacol; 1982 Mar; 21(2):387-93. PubMed ID: 6808349
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Spectrophotofluorometric evidence of negatively cooperative binding of warfarin and phenylbutazone to human serum albumin.
    Madsen BW; Tearne PD
    Life Sci; 1980 Jan; 26(3):173-9. PubMed ID: 7360001
    [No Abstract]   [Full Text] [Related]  

  • 9. Development of tryptophan-modified human serum albumin columns for site-specific studies of drug-protein interactions by high-performance affinity chromatography.
    Chattopadhyay A; Tian T; Kortum L; Hage DS
    J Chromatogr B Biomed Sci Appl; 1998 Sep; 715(1):183-90. PubMed ID: 9792509
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Rat alpha-foetoprotein. Purification, physicochemical characterization, oestrogen-binding properties and chemical modification of the thiol group.
    Versée V; Barel AO
    Biochem J; 1978 Oct; 175(1):73-81. PubMed ID: 83865
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evidence for a large and flexible region of human serum albumin possessing high affinity binding sites for salicylate, warfarin, and other ligands.
    Kragh-Hansen U
    Mol Pharmacol; 1988 Aug; 34(2):160-71. PubMed ID: 3412320
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The modification of the lone tryptophan residue in human serum albumin by 2-hydroxy-5-nitrobenzyl bromide. Characterization of the modified protein and the binding of L-tryptophan and benzodiazepines to the tryptophan-modified albumin.
    Fehske KJ; Müller WE; Wollert U
    Hoppe Seylers Z Physiol Chem; 1978 Jun; 359(6):709-17. PubMed ID: 97201
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The lone tryptophan residue of human serum albumin as part of the specific warfarin binding site. Binding of dicoumarol to the warfarin, indole and benzodiazepine binding sites.
    Fehske KJ; Müller WE; Wollert U; Velden LM
    Mol Pharmacol; 1979 Nov; 16(3):778-89. PubMed ID: 93690
    [No Abstract]   [Full Text] [Related]  

  • 14. Optical studies into the nature of the high affinity binding site of human serum albumin for phenylbutazone.
    Maes V; Hoebeke J; Vercruysse A; Kanarek L
    Mol Pharmacol; 1979 Jul; 16(1):147-53. PubMed ID: 481416
    [No Abstract]   [Full Text] [Related]  

  • 15. Cooperative interaction of warfarin and phenylbutazone with human serum albumin.
    Madsen BW; Ellis GM
    Biochem Pharmacol; 1981 Jun; 30(11):1169-73. PubMed ID: 7271816
    [No Abstract]   [Full Text] [Related]  

  • 16. Determination of the affinity of drugs toward serum albumin by measurement of the quenching of the intrinsic tryptophan fluorescence of the protein.
    Epps DE; Raub TJ; Caiolfa V; Chiari A; Zamai M
    J Pharm Pharmacol; 1999 Jan; 51(1):41-8. PubMed ID: 10197416
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of drug binding interactions on human, rat and rabbit serum albumin using high-performance displacement chromatography.
    Aubry AF; Markoglou N; McGann A
    Comp Biochem Physiol C Pharmacol Toxicol Endocrinol; 1995 Nov; 112(3):257-66. PubMed ID: 8838677
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of phenylbutazone, tolbutamide, and clofibric acid on binding of racemic warfarin and its enantiomers to human serum albumin.
    Veronich K; White G; Kapoor A
    J Pharm Sci; 1979 Dec; 68(12):1515-8. PubMed ID: 529041
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Species differences of serum albumins: I. Drug binding sites.
    Kosa T; Maruyama T; Otagiri M
    Pharm Res; 1997 Nov; 14(11):1607-12. PubMed ID: 9434282
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Circular dichroic examination of the interaction of some planar acidic drugs with tryptophan-modified human serum albumin.
    Vallner JJ; Perrin JH
    J Pharm Pharmacol; 1981 Nov; 33(11):697-700. PubMed ID: 6171635
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.